Answers are grounded in this paper and cite their sources.
Cell replacement therapy holds promises for treatment of patients suffering from diabetes mellitus. When determining the appropriate strategies to amplify the amount of transplantable beta-cells, sufficient knowledge of the developmental programs regulating beta-cell differentiation is crucial. Here, we describe the plasticity of the different pancreatic cell types in vivo and in vitro and their potential to serve as beta-cell progenitor.
No takes yet. Share an insight, caveat, or question.
Baeyens et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: